Lactic Acidosis During Entecavir(ETV)Treatment

PHASE4TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Lactic Acidosis
Interventions
DRUG

entecavir, lamivudine

"entecavir: 0.5mg/day p.o until development of lactic acidosis, OLT, death, or improvement of hepatic or renal function to MELD score less than 18 and participants will be followed for the duration of hospital stay, an expected average of 8 weeks.~lamivudine: 100mg/day p.o until development of lactic acidosis, OLT, death, or improvement of hepatic or renal function to MELD score less than 18 and and participants will be followed for the duration of hospital stay, an expected average of 8 weeks."

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER